Search

Compugen Ltd

Uždarymo kaina

2.34 4.93

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

2.22

Max

2.34

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-65M

-7.7M

Pardavimai

-65M

2.2M

P/E

Sektoriaus vid.

5.95

64.641

Pelnas, tenkantis vienai akcijai

-0.08

Pelno marža

-352.436

Darbuotojai

75

EBITDA

-64M

-7.7M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+123.21% upside

Dividendai

By Acuity

Kitas uždarbis

2026-08-03

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-45M

225M

Ankstesnė atidarymo kaina

-2.59

Ankstesnė uždarymo kaina

2.34

Compugen Ltd Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-07-29 23:56; UTC

LifeVantage Corp shares are trading lower in after-market hours. No specific news was identified to explain this movement.

2026-07-29 23:56; UTC

Zoom Video Communications Inc is trading lower in after-market hours. Broader market uncertainty regarding future interest rate decisions may be influencing investor sentiment.

2026-07-29 23:56; UTC

Harrow Inc shares are lower in after-market hours amid broad weakness in the Pharmaceuticals sub-sector, with the price significantly below its 20-day moving average.

2026-07-29 23:56; UTC

Sprinklr Inc. shares are higher in after-market trading, continuing an upward trajectory amid positive market sentiment following the Federal Reserve's expected interest rate decision.

2026-07-29 23:56; UTC

Becton Dickinson and Co shares are higher in after-market hours, maintaining momentum from Wednesday's close amid uncertainty over future interest rate decisions.

2026-07-29 23:56; UTC

News

Industrial Logistics Properties Trust shares declined after second-quarter results missed expectations, reporting a loss of -$0.22 per share and revenue of $114.12 million.

2026-07-29 23:56; UTC

Archer-Daniels-Midland shares are higher in after-hours trading, reflecting stability despite no specific news to explain the movement.

2026-07-29 23:56; UTC

Correlated Moves

Corsair Gaming Inc shares are higher in after-market trading, supported by positive sentiment and strength in small-cap stocks, including the Russell 2000 Index.

2026-07-29 23:56; UTC

Standard BioTools Inc. shares traded roughly flat during after-market hours, showing little change since Wednesday's close amid a stable trading range.

2026-07-29 23:56; UTC

Axon Enterprise Inc. shares advanced slightly in after-market trading, reflecting routine performance, though they remain below their 20-day moving average.

2026-07-29 23:56; UTC

Correlated Moves

Pentair PLC shares are higher in after-market trading, reflecting a positive trend in the Russell 2000 Index and steady interest rates from the Federal Reserve.

2026-07-29 23:56; UTC

Correlated Moves

Cloudflare Inc. trades higher in after-market hours, reflecting strength near its one-month range. The move aligns with trends in the cybersecurity sector.

2026-07-29 23:56; UTC

Clorox Co. shares declined in after-market trading, despite recovering from earlier lows. The stock remains above its 20-day moving average.

2026-07-29 23:56; UTC

Correlated Moves

Okta Inc shares rose in after-market trading, reflecting positive momentum in the cybersecurity sector and broader market sentiment regarding steady interest rates.

2026-07-29 23:56; UTC

Correlated Moves

DR Horton shares are higher in after-market trading, supported by a rising Russell 2000 Index and stable interest rate expectations from the Federal Reserve.

2026-07-29 23:56; UTC

Trade Desk Inc. shares are lower in after-market trading, despite remaining above their 20-day moving average after four consecutive higher daily closes.

2026-07-29 23:56; UTC

Powell Industries shares are higher in after-market trading, despite a generally flat cumulative return and ongoing uncertainty regarding interest rates.

2026-07-29 23:56; UTC

News

Adobe shares rose after-market, reaching about $263.62. Elevated options volume and a lower put/call ratio reflect bullish sentiment.

2026-07-29 23:56; UTC

Correlated Moves

Energy Fuels Inc shares are higher in after-market hours, reflecting a correlation with Cameco Corp's recent gains amid broader market uncertainty over interest rates.

2026-07-29 23:56; UTC

AeroVironment Inc shares are higher in after-market trading, reflecting a modest gain since Wednesday's close amid cautious market sentiment regarding interest rate expectations.

2026-07-29 23:56; UTC

Campbell Soup Co. shares traded higher in after-market hours, remaining above the 20-day moving average and near the upper end of their one-month range.

2026-07-29 23:56; UTC

Correlated Moves
ETF Constituents
Macro News

Financial Select Sector SPDR Fund trades higher in after-market hours, supported by gains from key holdings and a rise in the Dow Jones Index.

2026-07-29 23:56; UTC

Alcoa Corp shares advanced modestly in after-market trading following Wednesday's close, amid uncertainty over future interest rate changes.

2026-07-29 23:56; UTC

Correlated Moves

Lennar Corp sees a modest increase in after-market trading, supported by positive market sentiment and a rise in the Russell 2000 Index.

2026-07-29 23:56; UTC

Alphabet Inc. shares declined in after-market trading, reflecting a cumulative drop since Wednesday's close and remaining below the 20-day moving average.

2026-07-29 23:56; UTC

Social Media

Alphabet Inc shares declined in after-market trading, remaining below their 20-day moving average amid ongoing market uncertainty about future rate hikes.

2026-07-29 23:56; UTC

Macro Event

Cardano is higher today amid expectations of a future Fed rate hike, despite ongoing geopolitical tensions and easing inflation data.

2026-07-29 23:56; UTC

News

Logitech International SA's quarterly report filing has led to shares trading higher in after-market hours, reflecting increased investor interest.

2026-07-29 23:56; UTC

Macro News
ETF Constituents

Utilities Select Sector SPDR Fund trades higher in after-market hours, buoyed by strong returns from NextEra Energy and Entergy amid rising geopolitical tensions.

2026-07-29 23:56; UTC

Viridian Therapeutics Inc shares are lower in after-market trading, with no specific news identified to explain the decline. Broader market uncertainty persists.

Akcijų palyginimas

Kainos pokytis

Compugen Ltd Prognozė

Kainos tikslas

By TipRanks

123.21% į viršų

12 mėnesių prognozė

Vidutinis 5 USD  123.21%

Aukščiausias 6 USD

Žemiausias 4 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Compugen Ltd kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

3 ratings

3

Pirkti

0

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Compugen Ltd

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I monotherapy clinical study in patients with advanced malignancies through sequential dose escalations; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.
help-icon Live chat